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Abstract 
Lactobacilli and bifidobacteria play a primary role in modulation of gut immunity. By considering 
that microbiota composition depends on various factors, including diet, we asked whether 
functional differences could characterize faecal populations of lactobacilli and bifidobacteria 
isolated from individuals with different dietary habits. 155 healthy volunteers who followed 
omnivorous, ovo-lacto-vegetarian or vegan diets were recruited at four Italian centres (Turin, 
Parma, Bologna and Bari). Faecal samples were collected; lactobacilli and bifidobacteria were 
isolated on selective media and their immunomodulatory activity was tested in mouse dendritic 
cells (DCs). Pre-incubation with lactobacilli increased LPS-induced expression of the maturation 
markers CD80 and CD86, whereas pre-incubation with bifidobacteria decreased such expression. 
Analysis of the cytokine profile indicated that strains of both genera induced down-regulation of IL-
12 and up-regulation of IL-10, whereas expression of TNF-  was not modulated. Notably, analysis 
of anti-inflammatory potential (IL-10/IL-12 ratio) showed that lactobacilli evoked a greater anti-
inflammatory effect than did bifidobacteria in the omnivorous group (P<0.05). We also found 
significantly reduced anti-inflammatory potential in the bacterial strains 
volunteers in comparison with those from the cognate groups from the other centres. In conclusion, 
lactobacilli and bifidobacteria showed a genus-specific ability of modulating in vitro innate 
immunity associated with a specific dietary habit. Furthermore, the geographical area had a 
significant impact on the anti-inflammatory potential of some components of faecal microbiota. 
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1. Introduction 
Several endogenous and environmental factors can impact both the composition and functionality of 
gut microbiota throughout life [1]. In particular, substantial evidence indicates that diet is 
instrumental in the structure and functionality of gut microbiota [2-6]. Epidemiologic evidence also 
suggests that modulation of immune response mechanisms in the gut can contribute to the 
development of gastrointestinal disorders and allergic diseases. In this context, lactobacilli and 
bifidobacteria are considered key players because they constitute important members of the normal 
intestinal microbiota in animals and humans, particularly bifidobacteria in infants [7,8 ]. The current 
knowledge of mechanisms by which intestinal microbiota influences both regulatory and effector 
components of the immune system highlights the importance of enterocyte and dendritic cell (DC) 
interactions. DCs are considered to be gate-keepers of the immune system, and their contact with 
microbiota is crucial for proper development of gut immunity [9]. This contact is essentially 
patches via M cells. Furthermore, subepithelial DCs may sample the microbiota by passing their 
dendrites between epithelial cells into the gut lumen [10]. However, the precise mechanisms by 
which intestinal microbiota can influence the development and function of DCs remain to be further 
elucidated. Additionally, the composition of a healthy microbiota, which is required to confer 
immune protection, is not known, nor is the influence of dietary habits to improve the function of 
the microbiota. Herein, we addressed these issues by establishing whether lactobacilli and 
bifidobacteria species and strains arising from specific diets actually translate to the modulation of 
immune function. We evaluated, for the first time, a large microbiological screening of lactobacilli 
and bifidobacteria isolated from individuals undergoing omnivorous, vegan and ovo-lacto-
vegetarian diets [11, 12] to determine their role in modulating in vitro immune markers of mouse 
dendritic cell functions. Our data revealed genus-specific effects of selected bacteria on the 
maturation of DCs, as well as on inducible immune mediators produced by DCs in vitro, thus 
establishing a differential degree of modulation of the phenotype of DCs. Importantly, the latter 
parameter was found to be dependent on dietary habit.  
2. Materials and Methods 
2.1. Participant recruitment and faecal sample collection 
Healthy adult volunteers (n=155) who followed an omnivorous (n= 55), ovo-lacto-vegetarian (n= 
53) or vegan (n= 47) diet for more than 1 year were recruited at 4 Italian centres (Bari, Bologna, 
Parma and Turin) [11-13] (https://clinicaltrials.gov; ClinicalTrials.gov Identifier: NCT02118857; 
MRMOVVD), as indicated in Table 1. The research was conducted according to the Declaration of 
Helsinki. Informed consent was obtained from all subjects. The compliance to the declared diet type 
was verified by means of a 7-day weighed food diary, completed every day for a total of 7 days 
[11]. Three faecal samples/volunteer (ca. 15 g) were collected for 3 consecutive weeks (once per 
week) at home, transferred to sterile tubes containing 10 ml of liquid Amies transport medium 
(Oxoid, Milan, Italy) and stored at 4°C. The specimens were then transported to the laboratory 
within 12 hours and immediately processed.  
 
2.2. Isolation and growth of lactobacilli and bifidobacteria  
10 g of faeces from each volunteer was homogenized with 90 ml of 2 
min in a stomacher (LAB Blender 400, PBI, Italy) at room temperature. Serial dilutions were 
prepared in , and 100 l aliquots of each dilution were included into Rogosa Agar 
(Oxoid) with 21 M acetic acid or spread onto Bifidobacterium Agar (Becton Dickinson, Milan, 
Italy) [12-14]. Growth conditions were aerobic at 30°C for 48 h and anaerobic at 37°C for 48-72 h 
for selection of mesophilic lactobacilli and bifidobacteria, respectively. For each faecal sample, 10 
random colonies were picked from appropriate plate dilutions for analysis in vitro [13, 15, 16] Cell 
morphology and cell motility of selected colonies were evaluated for genus confirmation [17]. 
Bifidobacteria were cultured in trypticase-phytone-yeast extract (TPY; Oxoid) at 37°C under 
anaerobic conditions and lactobacilli in de Man, Rogosa and Sharpe medium (MRS; Oxoid) at 30°C 
under aerobic conditions; cells were collected during exponential growth phase. Randomly selected 
cultures were finally checked by PCR-DGGE and sequencing of amplimers [13]. Cell concentration 
was evaluated by measuring optical density at 600 nm and converting this value to the 
corresponding CFU ml-1 value. Bacteria were irradiated with 2800 Gy (Gray) of -irradiation by 
Gamma-Cell 1000 (MDS Nordion, Canada) to prevent their proliferation before being used as 
stimuli for DCs. 
 
2.3. Mice 
BALB/c mice were maintained under pathogen-free conditions at the animal facility of the Institute 
of Food Sciences. Mice were used at 6-12 weeks of age and were euthanized by inhalation of 
anaesthesia with isoflurane. These studies were approved by the National Institutional Review 
Committee. 
 
2.4. Isolation of bone marrow-derived dendritic cells 
Murine DCs were generated according to a previously published method [18]. In brief, bone 
marrow cells from the femurs and tibiae of mice were flushed, and bone marrow cell aliquots (2x 
106) were diluted in 10 ml of RPMI 1640 medium supplemented with 25 mM HEPES, antibiotics 
(penicillin 100 IU ml-1, streptomycin 100 IU ml-1), 10% foetal calf serum and 20 ng ml-1 
granulocyte-macrophage colony-stimulating factor (GM-CSF) (culture medium) before being 
seeded in 100-mm petri dishes (Falcon, Heidelberg, Germany). On day 3, 10 ml of culture medium 
was added and on day 7, 10 ml of the culture medium was replaced with freshly prepared medium. 
On day 9, non-adherent DCs were harvested by gentle pipetting. Cell aliquots (1x 106 ml-1) were 
then placed in 24-well plates and incubated in culture medium with 5 ng ml-1 GM-CSF. Cell 
viability was microscopically evaluated by dye-exclusion test using Nigrosin (1% solution) and > 
90% live cells were found in all experiments.  
 
2.5. Microbial challenge 
DCs (1x 106 ml-1) were incubated for 24 h with irradiated bacteria resuspended in complete RPMI 
medium at a 30:1 bacteria (CFU):DC (n) ratio. Following incubation, cells were treated with 1 µg 
ml-1 LPS for 6 h (LPS pulse) to induce the maturation of DCs and cultured for 0-24 h in complete 
RPMI medium. Cells were collected for RNA analysis. Spent media was centrifuged at 10,000 x g 
for 10 min to eliminate any residual cells and cell debris, and supernatants were stored at -80°C. No 
pH change occurred in the medium after 24 h of bacterial incubation.  
 
2.6. FACS analysis  
DCs were stained with phycoerythrin (PE)- or fluorescein isothiocyanate (FITC)-conjugated Abs 
(BioLegend, San Diego, CA, USA) against CD11b, CD11c, CD80 and CD86. Cell staining was 
analysed  using a CyFlow Space flow cytometer (Partec, Munster, Germany) and FlowJo software 
(Tree Star Inc., Ashland, OR, USA). For each Ab, an isotype control of the appropriate subclass 
was used. 
 
2.7. Analysis of cytokine production  
Total RNA was extracted from DCs using the TRIzol Reagent (Life Technologies Italia, Monza 
MB, Italy) 
RiboGreen RNA Reagent (Invitrogen Corp., Carlsbad, CA, USA), and RNA quality was verified by 
denaturing gel electrophoresis. cDNA was prepared from 1 g of total RNA by reverse transcription 
with M-MLV Reverse Transcriptase (Invitrogen) and Oligo-(dT)12-18 Primer at 42°C for 60 min. 
Real-time PCR was performed using the iCycler iQTM Real-Time Detection System (Bio-Rad, 
Hercules, CA, USA). A , containing iQTM 
SYBR Green Supermix (Bio-
39 cycles were 95°C for 30 s, 54.6°C (L-32), 60°C (IL-12, TNF- ), or 66.0°C (IL-10) for 30 s, and 
72°C for 40 s. The relative gene expression levels of TNF- , IL-12p40 and IL-10 were calculated 
using the CT method and presented as fold change in gene expression after normalization to the 
L-32 housekeeping gene. The following primer sequences were designed and used in this study: L-
-AGCAGAGCTGGAGTCGCTTT- , -
GGAGCTGCCATCCAAAAGATACTA- - , forward 5'-
CATCTTCTCAAAATTCGAGTGACAA-3', reverse 5'-TGGGAGTAGACAAGGTACAACCC-3'; 
IL12p40, forward 5'-GGAAGCACGGCAGCAGAATA-3', reverse 5'-
AACTTGAGGGAGAAGTAGGAATGG-3'; IL-10, forward 5'-
GACAATAACTGCACCCACTTC-3', reverse 5'-AGCTGGTCCTTTGTTTGAAAGAAA-3'. 
Supernatants from DC cultures were analysed for IL-12, TNF- -10 protein levels by 
sandwich-
each well of a 96-well plate (Nunc Maxisorb; eBioscience Inc., San Diego, CA) and incubated 
overnight at 4°C. Aft
2% BSA (blocking buffer) was added to each well and incubated at room temperature for 2 h. Next, 
cytokine standards and samples diluted in blocking buffer supplemented with 0.05% Tween-20 
were added to the respective wells and incubated overnight at 4°C. After incubation, three washing 
steps with PBS supplemented with 0.05% Tween-20 were performed, and 
antibody solution was added to the wells and incubated for 2 h at room temperature. After three 
washes, streptavidin horseradish peroxidase conjugate (1:2000 dilution; BioLegend) was added to 
the wells and incubated for 1 h at room temperature. Finally, a
Na2HPO4, 29 mM citric acid (pH 6.0) containing 0.66 mg ml-1 o-phenylenediamine/HCl and 0.05% 
hydrogen peroxide were dispensed into each well, and the wells were allowed to develop. The 
absorbance was read at 415 nm and the cytokine concentrations were calculated using standard 
curves and expressed as pg ml-1. 
 
2.8. Statistical analysis 
Statistical significance was determined by the Kruskal-Wallis test and Dunn's post-hoc test analysis 
using GraphPad PRISM 4.0 software (GraphPad Software, Inc., La Jolla, CA). A P-value of 0.05 or 
less was considered to be significant.  
3. Results 
3.1.  Modulation of maturation markers by diet-selected lactobacilli and bifidobacteria  
To preliminarily examine the effects of bacterial pre-incubation on DC maturation lactobacilli and 
bifidobacteria isolated from individuals undergoing different diet regimens were evaluated 
(lactobacilli from subjects n. 3, 18 and 42; bifidobacteria from subjects n. 14, 21 and 39 of Table 1). 
DCs were mainly CD11b-CD11c+ (data not shown) with low expression of the co-stimulatory 
molecules CD80 and CD86 (Fig. 1, iDCs). Incubation with the TLR4 ligand LPS for 6 hours 
resulted in increased expression of CD80 and CD86 surface maturation markers, although to 
different degrees in each independent experiment, as a consequence of heterogeneity in the iDC 
population (Fig. 1, mDCs). Pre-incubation with lactobacilli further increased the number of 
CD80+CD86+ cells (Fig. 1, subjects n. 3, 18 and 42). On the contrary, pre-treatment with all three 
bifidobacteria isolates caused a reduction in LPS-inducible expression of CD80 and CD86 (Fig. 1, 
subjects n. 14, 21 and 39). Next, we analysed the whole bacteria collection by expressing the 
number of double positive cells in terms of  % of the positive control (mDCs). The results shown in 
Fig. 2 indicated that the response varied widely both for lactobacilli (Fig. 2a) and bifidobacteria 
(Fig. 2b). Nevertheless, it was statistically confirmed that pre-treatment with lactobacilli mainly 
increased the LPS-induced expression of maturation markers, whereas pre-incubation with 
bifidobacteria decreased such expression. In addition, we reported that when increases of CD80 and 
CD86 were induced by bifidobacteria isolates, they never reached the higher levels generated by 
lactobacilli (Fig. 2a, b). Importantly, the examined diet regimens were not translated into changes in 
modulatory activity of either lactobacilli or bifidobacteria. Furthermore, no differences were found 
by examining these data on the basis of their geographical origin (data not shown). 
 
3.2. Setup of the cytokine analysis in vitro 
Real-time PCR reactions were performed under gene-specific conditions to amplify IL-12p40, IL-
10 and TNF-  cDNAs, with L-32 as a housekeeping gene. Kinetic analysis of cytokine 
transcription induced by a LPS pulse in DCs showed that in this model, the examined transcripts 
promptly peaked at the end of the pulse (IL-12 and TNF- ) or 1 h later (IL-10); then, they were 
rapidly down-regulated following removal of the mitogen (Fig. 3a). Therefore, cytokine mRNA 
levels were definitively assessed 1 h after the LPS pulse and compared to cognate protein levels, 
which were analysed in the supernatants of parallel cultures 24 h later. To preliminarily estimate the 
effects of bacterial pre-incubation of iDCs on cytokine expression, we tested lactobacilli isolates 
collected for three consecutive weeks from subjects n. 3, 18 and 42, who were subjected to different 
diet regimens. IL-12 mRNA levels were differentially regulated by the bacterial samples, but the 
final outcome was suppression of protein expression in all cases (Fig. 3b, upper panel), suggesting 
stringent post-transcriptional control of this cytokine by lactobacilli. On the contrary, IL-10 was 
significantly up-regulated by all samples at the transcriptional level (Fig. 3b, middle panel). TNF-  
mRNA was significantly down-regulated even when basal expression of the protein was generally 
unaffected by lactobacilli challenge (Fig. 3b, bottom panel). By comparing the samples collected in 
different weeks, we could detect quantitative differences in regulation only for IL-10.  
 
3.3. Modulation of the cytokine profile by diet-selected lactobacilli and bifidobacteria  
On the basis of the setting up analysis, bacterial collections were screened by determining cytokine 
protein levels, and data were expressed as % of the positive control (mDCs). Then, results from 
each independent experiment were pooled and reported in Fig. 4 and Fig. 5. It was confirmed that 
maturation of iDCs caused significantly increased expression of IL-12 (Fig. 4a, b) and TNF-  (Fig. 
5a, b). On the contrary, analysis of regulatory IL-10 in a larger sample size indicated that an 
increase in cytokine protein levels was not consistently obtained by LPS pulse (Fig. 4c, d), 
reflecting a higher sensitivity of this cytokine to cell heterogeneity of iDCs in different experiments. 
Pre-incubation with both lactobacilli and bifidobacteria collections generated a wide range of values 
in the cytokine response. Nevertheless, we found that both genera induced a statistically relevant 
down-regulation of IL-12 expression that resulted independently of the dietary regimen (Fig. 4a, b). 
On the other hand, pre-incubation with both lactobacilli and bifidobacteria isolates significantly up-
regulated IL-10 expression, once again independently of diet (Fig. 4c, d). Yet, expression of the 
pleiotropic cytokine TNF-  was not significantly modulated by pre-incubation with lactobacilli 
(Fig. 5a) or bifidobacteria (Fig. 5b). We have shown that, although statistically relevant, both the 
IL-12 and IL-10 responses varied widely; therefore, to more stringently analyse the impact of 
dietary regimen, we calculated anti-inflammatory potential in terms of the IL-10/IL-12 ratio from 
each microbial sample. The results reported in Fig. 6 indicated that most of the examined samples 
had a ratio >1, thus confirming the overall anti-inflammatory activity for both lactobacilli and 
bifidobacteria. Importantly, a statistically significant higher anti-inflammatory potential was 
observed for lactobacilli (median >10) in comparison with bifidobacteria in the omnivorous group. 
Interestingly, by further examining these data on the basis of geographical origin, we found reduced 
IL-10/IL-12  ratios in the isolates collected from Bari in comparison with the cognate groups from 
all other centres (Fig. 7a, b); specifically, the Dunn's post-hoc test analysis revealed significant 
differences between isolates from the vegan group recruited in Turin and those from the vegetarian 
group in Bari among lactobacilli (Fig. 7a) and between isolates from omnivores recruited in Turin 
and Bari among bifidobacteria (Fig. 7b). 
4. Discussion 
In this study, we found a genus-specific ability to modulate in vitro mechanisms of innate immunity 
by faecal populations of lactobacilli and bifidobacteria that was also influenced by the dietary habit. 
Gut microbiota shapes host immunity by inducing maturation of the gastrointestinal lymphoid 
tissue. In addition, other mediators, such as polysaccharide A and short-chain fatty acids (SCFAs), 
have been shown to stimulate Treg-cell differentiation. In particular, SCFAs can induce IL-10 and 
retinoic acid from DCs, which play a major role in mucosal tolerance [19]. Interestingly, a 
significant association between consumption of agrarian-based diets and increased levels of faecal 
SCFAs has been previously found in the individuals herein examined [11]. Furthermore, the 
culturable lactic acid bacteria (LAB) loads were found to be lower in the vegan and ovo-lacto-
vegetarian groups [12]. On the contrary, no significant difference between the ovo-lacto-vegetarian 
and omnivorous groups was observed in relation to the culturable bifidobacteria load, although such 
load was significantly lower in the vegan group [12]. It is well known that the composition and 
density of microbiota fluctuates with age and can also be influenced by various factors, including 
diet. Nevertheless, by two years of age, the gut microbiota is essentially dominated by members 
belonging to the Firmicutes and Bacteroidetes phyla and begins to resemble an adult microbiota 
[20]. Among the factors, diet clearly influences the developing gut microbiota: after the 
introduction of solid food, the diversification of Bacteroides spp. and Clostridium spp. rapidly 
increases, whereas the proportion of Bifidobacterium spp. stabilizes [20]. Lactobacilli numbers 
found in stool samples seem to be more specifically related to the ingestion of fermented foods. 
Importantly, strong evidence suggests a primary role of both lactobacilli and bifidobacteria in 
modulation of immune mechanisms in the gut. Therefore, we addressed this issue by evaluating 
whether, beyond differences in numbers and species [12], genus-specific functional differences
could characterize these bacteria isolated from the screened groups. For each faecal sample, 10 
random colonies were picked for analysis from adequate plate dilutions. It has been reported that  
colonies provide an adequate representation of the major bacterial strains cultured on a selective 
medium [15, 16]. We found that immunological outcomes widely varied within each group, 
suggesting that no bias was introduced by the strategy of bacteria isolation that we adopted. 
Nevertheless, due to the large number of individuals included in the examined groups, most data 
were found to be statistically significant. Specifically, we showed that bacteria belonging to the 
Lactobacillus genus further increased the number of CD80+CD86+ mDCs, whereas this number was 
decreased by bifidobacteria. To the best of our knowledge, this is the first work showing that the 
two genera may differentially alter the level of DC activation. Both CD80 and CD86 bind to CD28 
and, with a lower affinity, to its homolog CTLA-4 (cytotoxic T-lymphocyte antigen 4) on T cells. 
CD28-CD80/86 ligation enhances T-cell proliferation, whereas CTLA-4-CD80/86 interaction 
inhibits T-cell responses [21]. Consequently, we speculated that the reduced expression of CD80 
and CD86 mediated by most of the screened bifidobacteria favours the latter interaction, and this 
could play a role in maintaining immune tolerance through interaction with CTLA-4. Clearly, the 
increased number of CD80+CD86+ mDCs generated by lactobacilli tend to preclude a crucial role 
for CTLA-4 in lactobacilli-mediated immune homeostasis in the gut. The results of cytokine 
analysis showed that, independently of the dietary regimen, members of both genera significantly 
down-regulated the pro-inflammatory cytokine IL-12 and up-regulated the regulatory cytokine IL-
10, whereas the expression of the multifunctional cytokine TNF-  was not significantly modulated. 
Interestingly, experiments showed a more heterogeneous influence of both genera on IL-12 
production and CD80+CD86+ surface expression than on IL-10 secretion. These results suggested 
the existence of strain-specific effects that act on DC mechanisms that make them competent to 
prime a Th1 response. These results were also in agreement with previous data highlighting 
substantial differences among lactobacillus strains in the capacity to induce IL-12 and TNF-  
production in DC [22]. Notably, the evaluation of anti-inflammatory potential, expressed in terms of 
the IL-10/IL-12 ratio generated from each sample, showed higher values for lactobacilli than for 
bifidobacteria in the omnivorous group. Taken together, they are suggestive of genus-specific 
mechanisms involved in DC education. A possible outcome of this differential activity could be the 
recruitment of different regulatory cells. Interestingly, oral administration of B. breve, but not L. 
casei, in mice has recently been found to induce IL-10-producing CD4+ T cells that possessed 
properties of Tr1 cells [23], suggesting that a specific bifidobacterium strain could maintain 
intestinal homeostasis through the induction of intestinal Tr1 cells, differently from lactobacilli. 
Further studies are then required to determine if this property could be considered genus-specific. 
It is known that long-term dietary intake influences the structure and functionality of gut microbiota 
in humans [24]. In the populations examined herein, in agreement with differences in counts for 
LAB and bifidobacteria [12], the long-term dietary regimens did generate differences in 
characterized immune features in the studied isolates. Furthermore, we found reduced anti-
inflammatory potential in the isolates collected in Bari in comparison with those from the groups at 
other centres. This finding was well in line with our previous results obtained in Caco-2 cells: 
lactobacilli collected from the vegetarian group recruited in Bari induced a significant increase in 
IL-8 expression [13]. By considering sample homogeneity for age, BMI and sex ratio at the 
different recruitment centres [11], genetic or unselected environmental factors could still influence 
how and from where a gut microbiota/microbiome is acquired. Interestingly, the significant 
differences between bifidobacteria isolates from omnivores recruited in Turin and Bari tended to 
exclude a role of diet for this specific feature. 
In conclusion, by examining the faecal lactobacilli and bifidobacteria isolates in groups with large 
sample sizes, we highlighted for the first time the existence of genus-specific differences in their 
immune-modulatory activity on DCs. In agreement with diet-related variations in plate counts of 
culturable LAB and bifidobacteria, we also found an association between crucial immune features 
of bacterial populations and a specific dietary habit. Finally, the geographical area had a significant 
impact on the anti-inflammatory potential of members of these bacterial genera.  
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Figure Legends 
Figure 1. FACS analysis of DCs from BALB/c mice. Immature DCs (iDCs) were challenged with 
irradiated lactobacilli (from subjects n. 3, 18 and 42 of Table 1) or bifidobacteria (from subjects n. 
14, 21 and 39 of Table 1) and then subjected to a 6-h LPS pulse to induce DC maturation (mDCs). 
Both iDCs and treated or untreated mDCs were double stained for CD80 and CD86. Data were 
collected from ungated cells and are representative of three independent experiments. 
 
Figure 2. Expression of the co-stimulatory markers CD80 and CD86 on the surface of mDCs. 
mDCs were pre-treated with irradiated lactobacilli (a) or bifidobacteria (b) isolates from adults who 
followed an omnivorous (n= 55, 40; a, b), ovo-lacto-vegetarian (n. 53, 36; a, b) or vegan (n. 47, 34; 
a, b) diet. Data were collected from ungated cells, and bars represent medians. *, P< 0.05; **, P< 
0.01. 
 
Figure 3. Setup of cytokine expression by DCs. a) Kinetic analysis of IL-12, IL-10 and TNF-  
transcription in iDCs in response to LPS pulse; values were calculated as fold change in gene 
expression and expressed as % of maximum induction. b) Comparison between mRNA and cognate 
protein levels for IL-12 (upper panel), IL-10 (middle panel) and TNF-  (bottom panel) of DCs pre-
treated with lactobacilli from subjects n. 3, 18 and 24 collected for three weeks. Cells and culture 
supernatants were collected as indicated in the Materials and Methods section and analysed for 
cytokine mRNAs and secreted protein expression by using real-time PCR and sandwich-type 
ELISA, respectively; values are expressed as % of control (unchallenged mDCs); columns represent 
the mean ± SD and are representative of three independent experiments. *, P< 0.05. 
 
Figure 4. Protein expression of IL-12 and IL-10 by mDCs. mDCs were pre-treated with irradiated 
lactobacilli (a, c) or bifidobacteria (b, d) isolates from adults who followed an omnivorous (n. 55, 
40; a and c, b and d), ovo-lacto-vegetarian (n. 53, 36; a and c, b and d) or vegan (n. 47, 34; a and c, 
b and d) diet before LPS pulse. Culture supernatants were collected after 24 h and analysed for IL-
12 (a, b) and IL-10 (c, d) expression by sandwich-type ELISA. Data were expressed as % of control 
(unchallenged mDCs); bars represent medians. **, P< 0.01; ***, P< 0.001. 
 
Figure 5. Protein expression of TNF-  by mDCs. mDCs were pre-treated with irradiated 
lactobacilli (a) or bifidobacteria (b) isolates from adults who followed an omnivorous (n= 55, 40; a, 
b), ovo-lacto-vegetarian (n= 53, 36; a, b) or vegan (n= 47, 34; a, b) diet before LPS pulse. Culture 
supernatants were collected after 24 h and analysed by sandwich-type ELISA. Data were expressed 
as % of control (unchallenged mDCs); bars represent medians. ***, P< 0.001. 
 
Figure 6. Anti-inflammatory potential of diet-selected lactobacilli and bifidobacteria. Cytokine 
values reported in Fig. 4 were expressed as IL-10/IL-12 ratios for each lactobacilli and 
bifidobacteria population from adults who followed an omnivorous, ovo-lacto-vegetarian or vegan 
diet. Bars represent medians. *, P< 0.05. 
 
Figure 7. Anti-inflammatory potential of lactobacilli and bifidobacteria analysed across diet and 
geography. Cytokine values reported in Fig. 4 were expressed as IL-10/IL-12 ratios for lactobacilli 
and bifidobacteria populations from adults recruited at four Italian centres who followed an 
omnivorous, ovo-lacto-vegetarian or vegan diet (see Table 1). Bars represent medians. *, P< 0.05; 
**, P< 0.01. 
 
Table 1. List of mesophilic lactobacilli and bifidobacteria isolates from human faecal samples 
in this study. 
*: n, number of subjects. 
**: code number, arbitrarily assigned to identify subjects. 
Recruitment 
Centre 
Bacteria Diet Regimen 
  Omnivorous (n*; code**) Vegetarian (n*; code**) Vegan (n*; code **) 
Turin 
Lactobacilli 15 (1-15) 12 (16-24; 26-28) 13 (30-42) 
Bifidobacteria 15 (1-15) 13 (16-23; 25-29) 
11 (30-33; 35; 36; 38-
42) 
Parma 
Lactobacilli 10 (43-52) 15 (53-67) 12 (68-79) 
Bifidobacteria 8 (45-52) 
11 (53; 54; 56-60; 62; 65-
67) 
9 (68; 71; 73-79) 
Bari 
Lactobacilli 15 (80-103) 12 (104-107; 109-116) 10 (120-129) 
Bifidobacteria 15 (80-103) 11 (105-113; 115; 116) 
12 (118-125; 127-
129) 
Bologna 
Lactobacilli 15 (130-144) 14 (145-158) 12 (159-170) 
Bifidobacteria 2 (136; 139) 1 (146) 2 (161; 166) 
Total 
Lactobacilli 55 53 47 
Bifidobacteria 40 36 34 
Table
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